Su1795 – Utilization of Anti-TNF Therapy (BIOLOGICS) in Children with Very Early Onset Inflammatory Bowel Disease (Veoibd) in a Large North American Cohort - Basavaraj Kerur, Eric I. Benchimol, Karoline B. Fiedler, Marisa Gallant, Jeffrey S. Hyams, Michael C. Stephens, Ying Lu, Marian D. Pfefferkorn, Razan Alkhouri, Jennifer A. Strople, Judith R. Kelsen, Leah Siebold, Alka Goyal, Joel R. Rosh, Neal S. Leleiko - Dissemin

Language
Login

Published in

Publishing House Zaslavsky, Gastroenterology, 6(156), p. S-614, 2019

DOI: 10.1016/s0016-5085(19)38432-x

Links

Publishing House Zaslavsky

Tools

Export citation

Search in Google Scholar

Su1795 – Utilization of Anti-TNF Therapy (BIOLOGICS) in Children with Very Early Onset Inflammatory Bowel Disease (Veoibd) in a Large North American Cohort

Journal article published in 2019 by Basavaraj Kerur, Eric I. Benchimol, Karoline B. Fiedler, Marisa Gallant, Jeffrey S. Hyams, Michael C. Stephens, Ying Lu, Marian D. Pfefferkorn, Razan Alkhouri, Jennifer A. Strople, Judith R. Kelsen, Leah Siebold, Alka Goyal, Joel R. Rosh, Neal S. Leleiko and other authors.

This paper was not found in any repository, but could be made available legally by the author.

This paper was not found in any repository, but could be made available legally by the author.

Full text: Unavailable

Green circle

Preprint: archiving allowed

Upload

Green circle

Postprint: archiving allowed

Upload

Green circle

Published version: archiving allowed

Upload

Policy details

Data provided by

SHERPA/RoMEO